ACADIA PHARMACEUTICALS INC — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
POS AM
PRE 14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001967940-25-000025 | May 16, 2025 | — |
| 144 | — | 0001967940-25-000026 | May 16, 2025 | — |
| UPLOAD | — | 0000000000-25-005177 | May 14, 2025 | — |
| S-3 | FORM S-3 | 0001193125-25-116883 | May 9, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-066231 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-065672 | May 7, 2025 | — |
| 4 | — | 0001415889-25-011875 | May 2, 2025 | May 1, 2025 |
| 4 | — | 0001415889-25-011872 | May 2, 2025 | May 1, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-058827 | Apr 25, 2025 | May 29, 2025 |
| ARS | ARS | 0000950170-25-058833 | Apr 25, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-082809 | Apr 16, 2025 | Apr 15, 2025 |
| 4 | — | 0001415889-25-010423 | Apr 8, 2025 | Apr 5, 2025 |
| 4 | — | 0001415889-25-010424 | Apr 8, 2025 | Apr 5, 2025 |
| 4 | — | 0001415889-25-009073 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | — | 0001415889-25-009068 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | — | 0001415889-25-009074 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | — | 0001415889-25-009075 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | — | 0001415889-25-009067 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | — | 0001415889-25-007299 | Mar 6, 2025 | Mar 5, 2025 |
| 144 | — | 0001972362-25-000241 | Mar 6, 2025 | — |
| 10-K | 10-K | 0000950170-25-029253 | Feb 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-027759 | Feb 26, 2025 | — |
| 4 | — | 0001415889-25-005574 | Feb 25, 2025 | Feb 23, 2025 |
| 4 | — | 0001415889-25-005575 | Feb 25, 2025 | Feb 23, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-020492 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-001609 | Feb 7, 2025 | — |
| 8-K | 8-K | 0001193125-24-275595 | Dec 11, 2024 | — |
| 3 | — | 0001415889-24-028883 | Dec 10, 2024 | Dec 9, 2024 |
| 4 | — | 0001415889-24-028884 | Dec 10, 2024 | Dec 9, 2024 |
| 8-K | 8-K | 0001193125-24-262556 | Nov 20, 2024 | Nov 18, 2024 |
| 4 | — | 0001415889-24-027294 | Nov 19, 2024 | Nov 17, 2024 |
| 4 | — | 0001415889-24-027292 | Nov 19, 2024 | Nov 17, 2024 |
| 4 | — | 0001415889-24-027293 | Nov 19, 2024 | Nov 17, 2024 |
| SC 13G/A | ACADIA PHARMACEUTICALS INC | 0000902664-24-006501 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122513 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-122322 | Nov 6, 2024 | — |
| 4 | — | 0001415889-24-025148 | Oct 15, 2024 | Oct 12, 2024 |
| 4 | — | 0001415889-24-023975 | Sep 25, 2024 | Sep 23, 2024 |
| 3 | — | 0001415889-24-023974 | Sep 25, 2024 | Sep 23, 2024 |
| 8-K | 8-K | 0001193125-24-223726 | Sep 23, 2024 | Sep 17, 2024 |
| S-8 | S-8 | 0001193125-24-223796 | Sep 23, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-203694 | Aug 20, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-203700 | Aug 20, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-203702 | Aug 20, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-203703 | Aug 20, 2024 | — |
| S-8 POS | S-8 POS | 0001193125-24-203704 | Aug 20, 2024 | — |
| 4 | — | 0001415889-24-021724 | Aug 20, 2024 | Aug 16, 2024 |
| 4 | — | 0001415889-24-021726 | Aug 20, 2024 | Aug 16, 2024 |
| 4 | — | 0001415889-24-021731 | Aug 20, 2024 | Aug 16, 2024 |
| S-8 POS | S-8 POS | 0001193125-24-203689 | Aug 20, 2024 | — |